Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00513539Phase 3Completed
A Phase 3 trial of porfimer sodium in cholangiocarcinoma (CCA), gallbladder cancer, biliary tract cancer (BTC), sponsored by University College London. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00513539.